Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Ophthalmology, 5(123), p. 1101-1111, 2016

DOI: 10.1016/j.ophtha.2016.01.011

Links

Tools

Export citation

Search in Google Scholar

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion

Journal article published in 2016 by Michael Larsen ORCID, Sebastian M. Waldstein, Francesco Boscia, Heinrich Gerding ORCID, Jordi Monés, Ramin Tadayoni ORCID, Siegfried Priglinger, Andreas Wenzel, Elizabeth Barnes, Stefan Pilz, William Stubbings, Ian Pearce
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

To assess the 12-month efficacy and safety profile of an individualized regimen of ranibizumab 0.5 mg driven by stabilization criteria in patients with macular edema secondary to central retinal vein occlusion (CRVO).